Clinical Trial Update: Activity of Mefloquine Against Urinary Schistosomiasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the antimalarial drug mefloquine for activity against urinary schistosomiasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Schistosomiasis

Drugs mentioned

• Mefloquine (Mefloquine)

Snippet

Sponsor: Albert Schweitzer Hospital | Conditions: Urinary Schistosomiasis | Phase 2 | Status: COMPLETED